• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRAF1通过以AKT依赖的方式增强对氧化磷酸化的代谢适应性来促进破骨细胞生成。

TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner.

作者信息

Kang Honglei, Peng Renpeng, Dong Yimin, Liao Fuben, Zhu Meipeng, Wang Pengju, Hu Shi-An, Hu Peixuan, Wang Jia, Liu Zheming, Song Kehan, Li Feng

机构信息

Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Research Institute of Shenzhen Huazhong University of Science and Technology, Shen Zhen, China.

Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Mol Ther. 2025 Mar 5;33(3):933-949. doi: 10.1016/j.ymthe.2025.01.040. Epub 2025 Jan 25.

DOI:10.1016/j.ymthe.2025.01.040
PMID:39863932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11897774/
Abstract

Tumor necrosis factor receptor-associated factor 1 (TRAF1) is a crucial signaling adaptor involved in multiple cellular events. However, its role in regulating osteoclastogenesis and energy metabolism remains unclear. Here, we report that TRAF1 promotes osteoclastogenesis and oxidative phosphorylation (OXPHOS). Employing RNA sequencing, we found that TRAF1 is markedly upregulated during osteoclastogenesis and is positively associated with osteoporosis. TRAF1 knockout inhibits osteoclastogenesis and increases bone mass in both normal and ovariectomized adult mice without affecting bone mass in childhood. Furthermore, TRAF1 promotes osteoclast OXPHOS by increasing the phosphorylation level of AKT. Mechanistically, TRAF1 functions to inhibit TRAF2-induced ubiquitination of Gβl, a known activator of AKT, and further upregulates AKT phosphorylation. Rescue experiments revealed that the inhibitory effects of TRAF1 knockout on osteoclastogenesis, OXPHOS, and bone mass are dependent on AKT. Collectively, our findings uncover a previously unrecognized function of TRAF1 in regulating osteoclastogenesis and energy metabolism, and establish a novel TRAF1-AKT-OXPHOS axis in osteoclasts.

摘要

肿瘤坏死因子受体相关因子1(TRAF1)是一种参与多种细胞事件的关键信号衔接蛋白。然而,其在调节破骨细胞生成和能量代谢中的作用仍不清楚。在此,我们报告TRAF1促进破骨细胞生成和氧化磷酸化(OXPHOS)。通过RNA测序,我们发现TRAF1在破骨细胞生成过程中显著上调,且与骨质疏松症呈正相关。TRAF1基因敲除抑制正常和去卵巢成年小鼠的破骨细胞生成并增加骨量,而不影响幼年小鼠的骨量。此外,TRAF1通过增加AKT的磷酸化水平促进破骨细胞的氧化磷酸化。机制上,TRAF1的作用是抑制TRAF2诱导的Gβl(一种已知的AKT激活剂)的泛素化,并进一步上调AKT磷酸化。拯救实验表明,TRAF1基因敲除对破骨细胞生成、氧化磷酸化和骨量的抑制作用依赖于AKT。总的来说,我们的研究结果揭示了TRAF1在调节破骨细胞生成和能量代谢方面以前未被认识的功能,并在破骨细胞中建立了一种新的TRAF1-AKT-氧化磷酸化轴。

相似文献

1
TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner.TRAF1通过以AKT依赖的方式增强对氧化磷酸化的代谢适应性来促进破骨细胞生成。
Mol Ther. 2025 Mar 5;33(3):933-949. doi: 10.1016/j.ymthe.2025.01.040. Epub 2025 Jan 25.
2
Role of Pink1 in Regulating Osteoclast Differentiation during Periodontitis.Pink1在牙周炎期间调节破骨细胞分化中的作用
J Dent Res. 2025 Jul;104(7):753-762. doi: 10.1177/00220345251315723. Epub 2025 Mar 12.
3
Peroxiredoxin 1 promotes proliferation and inhibits differentiation of MC3T3-E1 cells via AKT1 / NF-κB signaling pathway.过氧化物酶 1 通过 AKT1/NF-κB 信号通路促进 MC3T3-E1 细胞的增殖和抑制分化。
J Oral Biosci. 2024 Jun;66(2):403-411. doi: 10.1016/j.job.2024.04.007. Epub 2024 Apr 23.
4
OTUD1 inhibits osteoclast differentiation and osteoclastic bone loss through deubiquitinating and stabilizing PRDX1.OTUD1通过去泛素化和稳定PRDX1来抑制破骨细胞分化和破骨性骨丢失。
Theranostics. 2025 Jun 9;15(14):6719-6736. doi: 10.7150/thno.111360. eCollection 2025.
5
Targeting lipid raft-related stomatin to ameliorate osteoporosis in preclinical models.在临床前模型中靶向脂筏相关的 stomatin 以改善骨质疏松症。
Nat Commun. 2025 Jul 1;16(1):5495. doi: 10.1038/s41467-025-60032-9.
6
Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.姜黄素通过抑制 RANK 信号及其下游 JNK-BCL2-Beclin1 通路抑制 RANKL 诱导的破骨细胞前体细胞自噬,从而抑制破骨细胞生成。
Biomed J. 2024 Feb;47(1):100605. doi: 10.1016/j.bj.2023.100605. Epub 2023 May 11.
7
The mechanosensitive adhesion G protein-coupled receptor 133 (GPR133/ADGRD1) enhances bone formation.机械敏感性黏附G蛋白偶联受体133(GPR133/ADGRD1)可促进骨形成。
Signal Transduct Target Ther. 2025 Jun 30;10(1):199. doi: 10.1038/s41392-025-02291-y.
8
Soybean isoflavone promotes milk yield and milk fat yield through the ERα-mediated Akt/mTOR pathway in dairy goats.大豆异黄酮通过雌激素受体α介导的Akt/mTOR信号通路促进奶山羊产奶量和乳脂产量。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae352.
9
Anti-osteoporosis effect of Semen Cuscutae in ovariectomized mice through inhibition of bone resorption by osteoclasts.菟丝子通过抑制破骨细胞骨吸收对去卵巢小鼠的抗骨质疏松作用。
J Ethnopharmacol. 2022 Mar 1;285:114834. doi: 10.1016/j.jep.2021.114834. Epub 2021 Nov 18.
10
Tectorigenin Ameliorates Glucocorticoid-Induced Osteoporosis by Inhibiting the NF-κB Signal Pathway and Modulating Treg-Th17 Cell Balance.知母皂苷元通过抑制NF-κB信号通路和调节Treg-Th17细胞平衡改善糖皮质激素诱导的骨质疏松症。
J Cell Mol Med. 2025 Jul;29(13):e70705. doi: 10.1111/jcmm.70705.

本文引用的文献

1
Extra-osseous Roles of the RANK-RANKL-OPG Axis with a Focus on Skeletal Muscle.RANK-RANKL-OPG 轴的骨外作用及其对骨骼肌的影响
Curr Osteoporos Rep. 2024 Dec;22(6):632-650. doi: 10.1007/s11914-024-00890-2. Epub 2024 Sep 26.
2
A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis.临床阶段 Nrf2 激活剂通过铁-鸟氨酸轴抑制破骨细胞分化。
Cell Metab. 2024 Aug 6;36(8):1679-1695.e6. doi: 10.1016/j.cmet.2024.03.005. Epub 2024 Apr 2.
3
Insights and implications of sexual dimorphism in osteoporosis.
骨质疏松症中性别二态性的见解与意义。
Bone Res. 2024 Feb 18;12(1):8. doi: 10.1038/s41413-023-00306-4.
4
β-Sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the PTEN/PI3K/AKT signaling pathway in ovarian cancer.β-谷甾醇靶向精氨酸琥珀酸合成酶1(ASS1)以进行Nrf2泛素依赖性降解,通过PTEN/PI3K/AKT信号通路诱导卵巢癌中活性氧(ROS)介导的细胞凋亡。
Free Radic Biol Med. 2024 Mar;214:137-157. doi: 10.1016/j.freeradbiomed.2024.02.004. Epub 2024 Feb 15.
5
Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases.解析破骨细胞分化和成熟的复杂性:探索针对破坏性骨疾病的新型治疗策略。
Exp Mol Med. 2024 Feb;56(2):264-272. doi: 10.1038/s12276-024-01157-7. Epub 2024 Feb 1.
6
IL13Rα2 as a crucial receptor for Chi3l1 in osteoclast differentiation and bone resorption through the MAPK/AKT pathway.IL13Rα2 通过 MAPK/AKT 通路作为 Chi3l1 在破骨细胞分化和骨吸收中的关键受体。
Cell Commun Signal. 2024 Jan 30;22(1):81. doi: 10.1186/s12964-023-01423-7.
7
Postmenopausal Osteoporosis.绝经后骨质疏松症
N Engl J Med. 2023 Nov 23;389(21):1979-1991. doi: 10.1056/NEJMcp2307353.
8
Lactate dehydrogenase A inhibition prevents RANKL-induced osteoclastogenesis by reducing enhanced glycolysis.乳酸脱氢酶 A 抑制通过降低增强的糖酵解来防止 RANKL 诱导的破骨细胞生成。
J Pharmacol Sci. 2023 Dec;153(4):197-207. doi: 10.1016/j.jphs.2023.09.005. Epub 2023 Sep 27.
9
Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress.人参皂苷Compound-K通过抑制RANKL诱导的破骨细胞生成和氧化应激来减轻去卵巢诱导的骨质疏松症。
Nat Prod Bioprospect. 2023 Nov 9;13(1):49. doi: 10.1007/s13659-023-00405-z.
10
Arginine methylation of PPP1CA by CARM1 regulates glucose metabolism and affects osteogenic differentiation and osteoclastic differentiation.精氨酸甲基化的 PPP1CA 由 CARM1 调节葡萄糖代谢,并影响成骨分化和破骨细胞分化。
Clin Transl Med. 2023 Sep;13(9):e1369. doi: 10.1002/ctm2.1369.